James Healy, Director at Karuna Therapeutics, Inc. (KRTX), bought 47 shares at $129.38 ($6K) on 2022-04-01, disclosed to the SEC on 2022-04-14.
Open-market purchase of $6k KRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |